Evidence map›Paper›PMID 36748515›Full record

ArticleMicrobial genomics2022

Genomic epidemiology of clinical ESBL-producing

Lisa Neffe, Taya L Forde, Katarina Oravcova, Ute Köhler, Wilfried Bautsch, Jürgen Tomasch, Susanne Häussler

Open access · goldAbstract read
In one paragraph

Article in Microbial genomics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. A community-based One Health approach to the pandemic dynamics ofAntimicrobial agents and chemotherapy · 2026
    Article
  2. Review
  3. Extended-Spectrum β-Lactamase-ProducingInfection and drug resistance · 2025
    Article
  4. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Lisa NeffeDepartment of Molecular Bacteriology, Helmholtz Center for Infection Research, Braunschweig, Germany.
Taya L FordeInstitute of Biodiversity, Animal Health and Comparative Medicine, University of Glasgow, Glasgow, UK.
Katarina OravcovaInstitute of Biodiversity, Animal Health and Comparative Medicine, University of Glasgow, Glasgow, UK.
Ute KöhlerStädtisches Klinikum Braunschweig gGmbH, Germany.
Wilfried BautschStädtisches Klinikum Braunschweig gGmbH, Germany.
Jürgen TomaschDepartment of Molecular Bacteriology, Helmholtz Center for Infection Research, Braunschweig, Germany.
Susanne HäusslerDepartment of Molecular Bacteriology, Helmholtz Center for Infection Research, Braunschweig, Germany.
Klinikum Braunschweig · DEUniversity of Glasgow · GBCopenhagen University Hospital · DKHelmholtz Centre for Infection Research · DEMedizinische Hochschule Hannover · DE

Funding

Biotechnology and Biological Sciences Research Council BB/R012075/1
6 · The paper itself

Abstract

Clinical

Indexed as

EnterobacteriaceaeEscherichia coli Infectionsbeta-LactamasesEscherichia coliGenomicsHospitalsHumansKlebsiella pneumoniaebeta-LactamasesE. coliepidemiologyESBLhospitalK. pneumoniae

Identifiers

PMID36748515
PMCPMC9837565
OpenAlexW4313321056

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.